Live
- Centre sanctions Rs 3,417 crore for 90 infra projects in Northeast states
- APSPDCL gearing up to promote solar panels
- Operation Chabutra conducted in Nalgonda town at midnight: DSP Sivarama
- Devotee rush normal in Tirumala to take 10 hours for Sarvadarshans
- ED team attacked in Delhi’s Bijwasan area during cyber crime probe
- Vijay Sales Announces its Black Friday Sale: Get upto 65% off at its retail stores and website
- Orient Cronos Pro Geyser Review: A Reliable Water Heating Solution for Modern Homes
- Don’t upload pix online, girls told
- Tenders called for new railway line
- Dr. Reddy's launches Toripalimab in India to treat rare form of head & neck cancer
Widest Nutrition Portfolio for Rare Metabolic Disorders
Abbott has announced increased access to Abbott’s nutrition metabolic formulas (ANMF) to help infants diagnosed with Inborn Errors of Metabolism (IEM) in India.
Abbott has announced increased access to Abbott’s nutrition metabolic formulas (ANMF) to help infants diagnosed with Inborn Errors of Metabolism (IEM) in India. The announcement comes on the back of easing of import regulations by the country’s regulatory authority – FSSAI (Food Safety and Standards Authority of India) under the Diet4Life initiative, which has made the movement of these critical medical foods simpler and faster into the country since November 2016. The final approval on IEM products came in June 2017.
India has one of the world’s highest birth rates. Of the nearly 74000 babies born every day, 74 will be born with IEM. On a yearly basis, this translates to more than 27,000 infants who need specialised nutrition and medical attention to be able to stay healthy, and even survive.
Speaking on IEM products availability in India, Pawan Kumar Agarwal CEO, FSSAI, “We are delighted to bridge the gap between critical patients’ needs and world class nutrition solutions by enabling easy entry into Indian market. FSSAI understands that treating IEM needs a holistic approach including neonatal screening, monitoring symptoms before arriving at the right nutrition therapy.
Through our “Diet4Life initiative,” we are not only addressing the access issue, but also creating an ecosystem of nutritionists and paediatricians to understand IEM better in the Indian context.” Amal Kelshikar, Country Head & General Manager, Abbott’s nutrition business in India, said, “We believe proper nutrition is foundational for living the best and fullest lives possible.
We are delighted to take the lead on making Abbott’s metabolic formulas available in India, and are grateful to FSSAI for enabling easy import of IEM and hypoallergenic products in the country that will help provide faster access to babies diagnosed with IEM disorders. Through a strong collaboration with government and third party organizations, we are able to give babies the chance to reach their full potential and live healthier lives.”
